19 Feb 2014
Clariant continues on profitable growth path in 2013
“Clariant has made good progress in 2013. The unfolding operational strength of the company became visible in a challenging economic environment. After the divestment of several businesses, Clariant is now a more profitable, less cyclical and well-balanced specialty chemicals player,” said CEO Hariolf Kottmann. “2014 will be a year of organic growth in the four Business Areas. This will bring us closer to our mid-term target to position Clariant in the top-tier of the specialty chemicals industry, characterized by an EBITDA margin before exceptionals between 16% and 19% in 2015 and beyond.”
12 Feb 2014
AVERY DENNISON REAFIRMA SU COMPROMISO SUSTENTABLE
Latinoamérica – 12 de febrero de 2014 – Avery Dennison, líder mundial en materiales para etiquetas y empaque, cerró el 2013 con un balance muy positivo en cuanto a acciones sustentables: se produjo un aumento significativo en la reducción de residuos enviados a rellenos en toda la región, en América del Sur en 2013 el porcentaje de residuos enviados para su reciclaje o generación de energía fue superior al 70 %, en comparación con 60% en 2012. Ronaldo Mello, Vice Presidente del Grupo Materiales de Avery Dennison América del Sur explica, "el resultado fue el fruto de todas las soluciones innovadoras construidas sobre tecnologías de vanguardia y en colaboración con nuestros clientes y proveedores".
12 Feb 2014
Healthcare market to profit from SABIC’s extended plastics portfolio, unveiled at Pharmapack 2014
SITTARD, The Netherlands, February 12, 2014 - SABIC is coming to Pharmapack Europe 2014 (Paris, February 12-13) to demonstrate its intent to further expand into the healthcare market. On Stand 354, SABIC will introduce two new pharmaceutical grades of polypropylene intended for syringes, other medical dosing application devices and also for packaging for healthcare applications. The two grades, SABIC® PP PCGR40 and a lubricated variant, SABIC® PP PCGR40L, are high-flow random copolymers typically used for producing thin-walled products with high levels of clarity.
12 Feb 2014
Clariant Healthcare Packaging promotes growing capacities and product offerings at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 - Clariant, a world leader in specialty chemicals, represented by its business line Healthcare Packaging, will exhibit its expanding portfolio of protective packaging for pharmaceuticals at Pharmapack Europe 2014 Paris. A long time leader in pharmaceutical desiccants, oxygen scavengers and specialized container closure systems, Clariant Healthcare Packaging, along with Clariant Medical Masterbatches, will once again present its solutions to customers at PharmaPack.
12 Feb 2014
Clariant Healthcare Packaging Collaborates with Pumpart for Airless Technologies for Protecting Pharmaceutical Creams
Muttenz, February 12, 2014 - Clariant, a world leader in specialty chemicals, through its Healthcare Packaging business segment, has announced a partnership and collaboration with PumpArt System® for the introduction of an innovative airless dispensing technology, Tubairless®, to the pharmaceutical industry.
12 Feb 2014
Clariant supports the ocular medicine packaging with launch of new global and compliant standard color range of masterbatches for caps and closures at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, In the Healthcare sector, coloration of plastics plays an important role in protecting patients by identifying drug types or doses, thereby reducing the risk of errors. However, these plastic packaging materials and the colorants in them need assessment of how they behave in contact with the drug during storage and use. These extractable and leachable studies on the packaging material, play an important role in medium and high risk applications such as ocular medicines, but if something changes in the polymers or masterbatches used to manufacture the packaging, then the data from the extractable and leachable studies may no longer be valid. To address these issues Clariant has used in dedicated expertise to create a new range of standard masterbatch colors, offering the benefits of the MEVOPUR® brand, tailored to the color standard developed by the American Society of Ophthalmology.
12 Feb 2014
Clariant opens the door for productivity and sustainability in pharmaceutical packaging with European Pharmacopeia tested additives
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, supports the Healthcare industry with a range of products developed for medical devices and pharmaceutical plastic packaging. With its knowledge, Clariant’s MEVOPUR® nucleant product brings improvements in the process of plastic packaging fabrication. Thanks to them the processing time can be reduced; mechanical properties improved and so companies can save time and increase the productivity. The nucleating agents used in MEVOPUR products are pre-tested using extraction protocols such as those established by US Pharmacopeia, ISO and NEW European Pharmacopeia monograph 3.1.3; the goal is helping companies to meet the challenging regulatory requirements to support “Controlled, Consistent and Compliant”.
12 Feb 2014
Clariant launches new ‘EP’ masterbatch range for pharmaceutical packaging at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, a world leader in specialty chemicals, Since the launch of the MEVOPUR® range of masterbatch and compounds for Healthcare applications at the end of 2010, Clariant has been active in bring new ideas and products to the market, with the objective of ‘Enhancing Products and Process’ and ‘Protecting the Patient and the Drug’. In particular in the last 12 months, new additive masterbatches have attracted high interest because Clariant had pre-tested the raw materials for the masterbatches using the extraction and biological evaluation protocols of US Pharmacopeia (USP) 23 parts 87 and 88. However initial feed-back raised the question of whether the substances were also listed European Pharmacopeia chapter 3.1.3 (EP 3.1.3). Clariant has reacted to this feed-back and recently completed a test programme on raw materials of its masterbatches, and is now offering products that use raw materials that have been pre-evaluated to both the above USP and EP standards.
